Ponatinib pulled off market over safety issues
Dalzell, M.D.
Managed Care 22(12): 42-43
2013
ISSN/ISBN: 1062-3388 PMID: 24558672 Document Number: 669109
Document emailed within 1 workday
Related Documents
Ghasem, S.; Negar, K. 2013: Effect of vitrification on number of inner cell mass in mouse blastocysts in conventional straw, closed pulled straw, open pulled straw and cryoloop carriers Jpma. Journal of the Pakistan Medical Association 63(4): 486-489Tatsuno, T.; Kamikura, M.; Ishida, Y.; Taniguchi, N. 1970: Studies on the safety of toys. IV. Safety of toys on market (colors and heavy metals) Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 88: 107-109
Offenbartl, K. 2008: "From blame and shame to patient safety work in an educational and nourishing environment". Patient safety issues belong on the "workshop floor" Lakartidningen 105(15): 1112
Hu, M. 2016: Issues confronted with biomaterials research and development and market access in craniomaxillofacial field Zhonghua Kou Qiang Yi Xue Za Zhi 51(11): 641-645
Deininger, M. 2014: The current status of ponatinib in the treatment of chronic myeloid leukemia Clinical Advances in Hematology and Oncology: H&o 12(5): 329-331
Behrman, J.R.; Wolfe, B.L. 1984: Micro determinants of female migration in a developing country: labor market, demographic marriage market and economic marriage market incentives Research in Population Economics 5: 137-166
Behrman, J.R.; Wolfe, B.L. 1984: Micro determinants of female migration in a developing country: labor market, demographic marriage market and economic marriage market incentives Research in Population Economics 5: 137-166
Onishchenko, G.G. 2007: Important issues of biological safety Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 12: 40-44
Rees, H 1994: Acquiring the pill: Safety issues Reproductive Health Matters 2(3): 41-45
Durazzi, N. 2017: Inclusive Unions in a Dualized Labour Market? the Challenge of Organizing Labour Market Policy and Social Protection for Labour Market Outsiders Social Policy-Administration 51(2): 265-285
Pal'tsevIu P; Levina, A.V.; Kravchenko, O.K. 2008: Issues of provision of the safety of laserwares in the use of nanotechnologies Gigiena i Sanitariia 2008(6): 29-31
Natuk, R.J.; Wade, M.S.; Chengalvala, M.; Murthy, K.K.; Chanda, P.K.; Murthy, S.C.; Bhat, B.M.; Bhat, R.; Dheer, S.K.; Mizutani, S. 1995: Adenovirus as vector for HIV: efficacy and safety issues Developments in Biological Standardization 84: 153-156
Feagan, B.G. 2001: Safety of biologics: current issues and future concerns Acta Gastro-Enterologica Belgica 64(2): 210-214
Michel, Ré.; Zorn, M.J. 2003: Radiation safety compliance issues at affiliated institutions Health Physics 85(5 Suppl): S78-S80
Kon, I.Ya.; Konovalova, L.S.; Georgieva, O.V. 2013: Issues of the support of the quality and safety of baby food Gigiena i Sanitariia 2013(1): 36-39
D'Angelo, S.; Palazzi, C.; Cantini, F.; Lubrano, E.; Marchesoni, A.; Mathieu, A.; Salvarani, C.; Scarpa, R.; Spadaro, A.; Olivieri, I. 2011: Etanercept in spondyloarthopathies. Part II: safety and pharmacoeconomic issues Clinical and Experimental Rheumatology 29(5): 865-870
Keystone, E.C. 2004: Safety issues related to emerging therapies for rheumatoid arthritis Clinical and Experimental Rheumatology 22(5 Suppl 35: S148-S150
McCracken, J.T. 2005: Safety issues with drug therapies for autism spectrum disorders Journal of Clinical Psychiatry 66(Suppl 10): 32-37
Lisella, F.S.; Herring, L.W. 1988: Promising biotechnology industry raises unique safety, health issues Occupational Health and Safety 57(6): 62
Segev, Y.; Riskin-Mashiah, S.; Lavie, O.; Auslender, R. 2011: Assisted reproductive technologies: medical safety issues in the older woman Journal of Women's Health 20(6): 853-861